/
© 2026 RiffOn. All rights reserved.

Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

  1. AI For Pharma Growth
  2. E213: The Diagnostic Room: We have AI initiatives, but do we have a strategy? The quickest self-test
E213: The Diagnostic Room: We have AI initiatives, but do we have a strategy? The quickest self-test

E213: The Diagnostic Room: We have AI initiatives, but do we have a strategy? The quickest self-test

AI For Pharma Growth · Apr 14, 2026

Pharma's AI initiatives often fail not from poor tech, but from misdiagnosing problems. A diagnostic before strategy is key to real ROI.

An AI Diagnostic's Purpose Is to Define the Right Problem, Not to Create a Strategy

A diagnostic is not a mini-strategy exercise that provides roadmaps or vendor recommendations. Its sole, critical function is to identify what's actually broken with specificity and evidence. This ensures that the subsequent, more substantial strategy work is built on a foundation of reality, not on internal assumptions.

E213: The Diagnostic Room: We have AI initiatives, but do we have a strategy? The quickest self-test thumbnail

E213: The Diagnostic Room: We have AI initiatives, but do we have a strategy? The quickest self-test

AI For Pharma Growth·a day ago

An External AI Diagnostic Creates a Shared, Evidence-Based Language for Misaligned Leadership

Leadership teams often lack a common way to discuss AI performance, leading to conversations based on conflicting hypotheses and vague frustrations. An independent diagnostic replaces these circular debates with a single, evidence-backed set of findings. This shared clarity is essential for making fast, aligned decisions.

E213: The Diagnostic Room: We have AI initiatives, but do we have a strategy? The quickest self-test thumbnail

E213: The Diagnostic Room: We have AI initiatives, but do we have a strategy? The quickest self-test

AI For Pharma Growth·a day ago

AI Business Cases Fail by Assuming the Very Organizational Structures That Are Broken

Most AI ROI models are optimistic projections, not true business cases. They fail because their financial assumptions about user adoption, data availability, and decision speed don't account for the fragmented governance and misaligned incentives that are constraining the organization. The model assumes a reality that doesn't exist.

E213: The Diagnostic Room: We have AI initiatives, but do we have a strategy? The quickest self-test thumbnail

E213: The Diagnostic Room: We have AI initiatives, but do we have a strategy? The quickest self-test

AI For Pharma Growth·a day ago

Pharma AI Initiatives Fail From Misdiagnosing Structural Flaws as Speed Problems

Companies believe AI isn't delivering because technology moves too fast, so they invest in training and agile frameworks. The real, invisible problems are structural: ambiguous decision rights, siloed data ownership, and misaligned employee incentives. Solving for 'speed' when the foundation is broken guarantees failure.

E213: The Diagnostic Room: We have AI initiatives, but do we have a strategy? The quickest self-test thumbnail

E213: The Diagnostic Room: We have AI initiatives, but do we have a strategy? The quickest self-test

AI For Pharma Growth·a day ago

Resist Immediately Fixing AI Issues; Structural Problems Demand a Full Strategic Response

After a diagnostic identifies deep issues like data governance or decision rights, the instinct is to assign a working group to fix it quickly. This is a mistake. These complex, structural problems require a rigorous, integrated strategic blueprint, not a fast-track task force. A quick fix produces a document nobody follows.

E213: The Diagnostic Room: We have AI initiatives, but do we have a strategy? The quickest self-test thumbnail

E213: The Diagnostic Room: We have AI initiatives, but do we have a strategy? The quickest self-test

AI For Pharma Growth·a day ago